The Vox Markets Podcast

Watch on YouTube In this week’s smallcap investing show, UK equity analyst & markets commentator Paul Scott & I discussed our latest thoughts on 22 stock ideas. 00:00 Key macro takeaways from past fortnight 01:55 JD Sports 03:00 PCI-Pal 07:20 Wise 09:00 Spectra Systems 15:35 Water Intelligence 21:35 Tate & Lyle 26:25 Treatt 30:15 Ixico 33:05 Animalcare 36:20 Mpac 41:00 Xaar 43:25 Avingtrans 47:40 Renew Holdings 50:10 Hercules 51:00 Hvivo 55:15 Venture Life 57:55 Capita 59:50 Facilities by ADF 1:06:25 Paypoint 1:08:40 Card Factory 1:11:40 OntheBeach 1:12:00 Ondine Biomedical #JD #PCIP #WISE #SPSY #WATR #TATE #TET #IXI #ANCR #MPAC #XAR #AVG #RNWH #HERC #HVO #VLG #CPI #ADF #PAY #CARD #OTB #OBI

MedPal AI has just acquired a licensed online pharmacy and raised £550k to support its next big move: entering the fast-growing GLP‑1 weight-loss market. With drugs like Ozempic and Mounjaro in high demand — and online prescribing facing tighter regulation — MedPal is combining AI health coaching with compliant, NHS-linked pharmacy fulfilment. CEO Jason Drummond joins Vox Markets to break down the deal, the strategy, and what’s next.

ECR Minerals has announced the acquisition of the Raglan alluvial gold project in Australia, in conjunction with a £650,000 fundraise. ECR's chairman joins us to explain the thinking behind the deal, which should make ECR cash generative next year.

Watch on YouTube Following Tuesday’s strong and in line H1’25 results, CEO Jerry Randall and CFO Danny Wells of Venture Life - a leading consumer healthcare products firm - kindly take me through the: 00:00 Recent strategic developments 03:40 Financial highlights 11:30 Future M&A and organic growth opportunities 15:30 New product development 17:05 Q3 trading & May FY26 outlook 20:45 Closing remarks

Watch on YouTube Metals One #MET1 has released its interim results in conjunction with news of a board reshuffle in which Dan Maling, one of the progenitors of the major financing the company undertook earlier in the year, becomes managing director. He joins Vox, along with Metals One executive chairman Craig Moulton, to talk us through the implications of the results and the company's wider strategy, now that the portfolio has expanded so significantly.

Watch on YouTubeShearwater Group plc #SWG is carving out its place in the booming cybersecurity market. In this introductory interview, their CEO, Phil Higgins explain how their subsidiaries work together, where growth will come from, and why retail investors should be paying attention now.

In this upbeat interview, Exec Chairman Patrick Desouza of Water Intelligence and CEO Will Knell of American Leak Detection take me through today’s strong H1’25 results and in line guidance.00:00 Key growth drivers, profit margin expansion and current demand given the impressive Q2 momentum.07:20 Progress wrt rolling out both the Dallas template, new products/services and customer feedback.15:50 International expansion, H2 outlook & closing remarks.

Watch on YouTube Poolbeg Pharma #POLB CEO Jerremy Skillington discusses the company’s H1 2025 results, a major update on POLB 001, and progress in the high-growth GLP-1 obesity space. A strong pipeline and multiple catalysts make this a story to watch

Watch on YouTubePoolbeg Pharma CEO Jeremy Skillington and Liam discuss the execution plan for their upcoming Phase 2a trial of POLB 001, a promising candidate in cancer immunotherapy. They detail the trial design, the selection of clinical partners, and the potential impact of the drug. Jeremy also outlines what investors can expect in the near term as the programme advances.

Watch on Youtube Pinnacle Silver and Gold has released its latest set of sample results from exploration at and around its two historic mine sites in Mexico. The results showed high grade silver and gold, and suggested a continuity of mineralisation between the surface and the underground former workings. A new vein is also under investigation nearby, and allowing for permits underground drilling could start fairly soon. Chief executive Bob Archer joins us with the full story